OP45 - 3024: Efficient lentiviral vector-mediated hematopoietic stem cell gene therapy in MNGIE mice

详细信息    查看全文

• 作者：R. Yadak ; J. Torres-Torronteras ; E. Bogaerts ; G. de Ruijter ; J. Barquinero ; R. Marti ; H.J. Smeets ; M.W. Huston ; N.P. van Til ; G. Wagemaker ; I.F.M. de Coo
• 刊名：European Journal of Paediatric Neurology
• 出版年：2015
• 出版时间：May 2015
• 年：2015
• 卷：19
• 期：supp_S1
• 页码：S15
• 全文大小：79 K

文摘

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) patients are deficient in thymidine phosphorylase (TP) resulting in systemic thymidine (Thd) and deoxyuridine (dUrd) accumulation affecting mtDNA replication and causing mitochondrial dysfunction. Common symptoms are gastrointestinal dysmotility, progressive ophthalmoplegia and leukoencephalopathy. Allogeneic hematopoietic stem cell (HSC) transplantation has been shown to reduce disease symptoms, but is not well tolerated due to the inherent toxicity of the procedure. Application of lentiviral vector therapy.

Methods

Therefore, syngeneic ex vivo lentiviral vector HSC gene therapy overexpressing the native cDNA or the codon optimized (TPco) sequence driven by the phosphoglycerate kinase (PGK) or spleen focus forming virus (SFFV) promoters in Tp-/-Upp-/- double knockout mice, a model for MNGIE disease, was investigated.

Results

At 1 month post transplantation after sublethal total body irradiation, very low TP activity was detected in blood of control wild type mice (0.07±0.03nmoles/h/mg), but enzyme activities in PGK treated mice were at least 90-fold higher (PGK-TP = 150±4 and PGK-TPco=96±4 nmoles/h/mg), compared to a 400-fold increase observed in SFFV recipient mice (450±5) and consequently, a significant reduction of plasma and urine Thd and dUrd levels was observed. Long-term follow up (14 months post treatment) showed on average 1.2-fold TP wild type activity levels in LV-PGK-TP and LV-PGK-TPco and 36-fold in SFFV-TPco treated mice, sufficient for sustained reduction of plasma and urine nucleoside levels, which was achieved at 76.5±8.2% donor chimerism levels with low LV vector copy numbers (1.0±1.1VCN/donor cell).

Conclusion

Overall, stem cell gene therapy provided stable TP expression and long-term biochemical correction in MNGIE mice without genotoxicity or apparent phenotoxicity, which will be further evaluated for somatic and neurological phenotype correction and optimized to develop a clinical protocol to treat MNGIE patients.